Nav: Home

Researchers develop drug-targeting molecules to improve cancer treatment

June 12, 2019

Researchers from the University of Notre Dame have developed small drug-targeting molecules that may be hundreds to thousands of times more effective at delivering potent drugs to desired sites of disease, including cancer.

According to the study published in ACS Central Science, a compound was developed from a new material, described as an easily injected hydrogel, which acts as a "homing" cue to attract drug molecules to sites bearing a tumor. By this method, the same sites can also be re-targeted for repeat dosing of chemotherapy or other treatments as needed.

"Common strategies, including several clinically approved therapeutics, use antibodies to direct a drug to its target. While offering biological recognition, these approaches only deliver a very small percentage of the drug to the site where it is needed while the remainder of the drug may circulate in the body for a very long time and cause increased toxicity," said Matthew Webber, assistant professor in the Department of Chemical and Biomolecular Engineering and senior author on the study. "As toxic as chemotherapy is, accurate drug-targeting paradigms are key to improving both the effectiveness of treatment as well as the quality of life for patients."

Instead of large protein-based targeting, Notre Dame researchers opted to use a small molecule. The size of the molecule is intended to improve tissue distribution and enable access to the desired site. In the case that the molecules do not make it to their target, their size also allows them to clear rapidly from the body, helping limit toxicity from chemotherapy.

"Our goal was to think about drug targeting in a new way," said Lei Zou, postdoctoral researcher in chemical and biomolecular engineering and lead author on the study. "This approach has allowed us to create something very different from what is currently available in the market, with the potential to improve the chemotherapy treatment experience for cancer patients."
-end-
The study was co-authored by Adam Braegelman, graduate student in the Bioengineering Graduate Program, and was funded by an American Cancer Society Institutional Research Grant through Notre Dame's Harper Cancer Research Institute. Webber is an affiliated member of the Harper Cancer Research Institute, Advanced Diagnostics and Therapeutics at Notre Dame, the Notre Dame Center for Nanoscience and Technology and the Warren Center for Drug Discovery.

University of Notre Dame

Related Chemotherapy Articles:

Nanotechnology improves chemotherapy delivery
Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.
Novel anti-cancer nanomedicine for efficient chemotherapy
Researchers have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.
Ending needless chemotherapy for breast cancer
A diagnostic test developed at The University of Queensland might soon determine if a breast cancer patient requires chemotherapy or would receive no benefit from this gruelling treatment.
A homing beacon for chemotherapy drugs
Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.
Chemotherapy or not?
Case Western Reserve University researchers and partners, including a collaborator at Cleveland Clinic, are pushing the boundaries of how 'smart' diagnostic-imaging machines identify cancers -- and uncovering clues outside the tumor to tell whether a patient will respond well to chemotherapy.
More Chemotherapy News and Chemotherapy Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...